Switch to
More onapp

IPCA Laboratories Ltd

IPCALAB
Health CarePharmaceuticals
MidcapWith a market cap of ₹21,602 cr, stock is ranked 206
Low RiskStock is 1.43x as volatile as Nifty
851.606.80 (-0.79%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹21,602 cr, stock is ranked 206
Low RiskStock is 1.43x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
24.44
PB RatioPB Ratio
3.88
Dividend YieldDiv. Yield
0.94%
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

43%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).

Financial TrendFinancial statements 

20192020202120223.804.695.485.900.440.611.140.88
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnJan 20, 2023

IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | Download

IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 11, 2023

IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022 | Download

IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022 | Download

Cash Dividend 
Ex. DateNov 22, 2022

Interim • Div/Share: ₹ 4

See all events